The Liberal National Government is supporting research that will help us understand the role of cognitive networks in Parkinson’s disease with the hope of leading to better treatment and self-management of the disease. Parkinson’s disease is a progressive, degenerative neurological condition that affects a person’s control of their body movements. It currently affects…
E&OE… Topics: Immunisation rates – No Jab, No Pay; Labor’s poor record on PBS; CFMEU; record child immunisation rates CHRIS KENNY: Now there has been a lot on focus in vaccination in recent years, the lack of vaccination in our communities. There some good news here that the No Jab, No Pay policy…
The Liberal National Government is investing almost $800,000 into research into how prostate cancer spreads and becomes resistant to normal treatments. Prostate cancer is the most commonly diagnosed cancer in Australia. It can be lethal when it spreads to other organs, and can become resistant to conventional therapies. Dr Philip Gregory, from the University of…
The Liberal National Government will provide $3 million for two studies that aims to reduce the debilitating symptoms attributed to tick bites. Thousands of Australians have had their lives, and those of their families, impacted by chronic symptoms associated with tick bites such as fatigue, arthritis, chronic pain, headaches and ongoing psychological symptoms. …
The Liberal National Government will make a medicine for the treatment of seizures associated with tuberous sclerosis more affordable, saving patients $17,000 a year. The medicine Afinitor® (everolimus) is being listed on the expert Pharmaceutical Benefits Scheme (PBS) from January 1, for the treatment of refractory seizures associated with tuberous sclerosis complex. The…
The Liberal National Government will make a medicine for a rare type of lung cancer caused by a gene defect affordable, saving patients $140,000 a year. From 1 January the medicine Xalkori® (crizotinib) will made available through the Pharmaceutical Benefits Scheme (PBS) for lung cancer patients with a c-ROS proto-oncogene 1 (ROS1) gene rearrangement.…
E&OE… Topics; Labor’s private health insurance policy forcing regional hospitals to cut services; Mavenclad listed on the PBS for MS MICHAEL MCLAREN: Look, from that back into the real world – good news for multiple sclerosis sufferers this Christmas Eve because patients are set to save $54,000 a year after the drug Mavenclad…
The Liberal National Government will list a new medicine for adults with genetic kidney disease on the Pharmaceutical Benefits Scheme (PBS), saving patients around $23,000 a year. Jinarc® (tolvaptan) will be available through the PBS from 1 January 2019. It is the first effective drug treatment for autosomal dominant polycystic kidney disease (ADPKD)…
For many, Christmas and New Year is a time of celebration with family, friends and loved ones. However, the end of year holiday season can also be a time when many people experience stress, anxiety, depression, or social isolation. Over this period, I want to encourage those seeking help to visit the Head…
The Liberal National Government will invest in world leading cancer research that will focus on more accurate diagnosis, more effective treatments and improved survivorship of a broad range of cancers. Our Government, through Cancer Australia, will invest $7.1 million in research grants, with an additional $4.7 million contributed by funding partners Cancer Council Australia,…